12:05 PM
 | 
Nov 26, 2018
 |  BC Innovations  |  Distillery Techniques

Biomarkers

TECHNOLOGY: Gene profiling

A Bayesian network-based method of analyzing non-silent mutations could help identify mutational interactions across different cancer types to predict patient outcomes and identify targets or new indications for drugs. The method involves using Bayesian modeling to analyze a set of sequenced primary tumor samples from cancer...

Read the full 220 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >